Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TriStar Technology Ventures Invests in GenomOncology

Published: Thursday, February 06, 2014
Last Updated: Thursday, February 06, 2014
Bookmark and Share
Chief Information Officer of MedCare joins board.

GenomOncology has announced the investment from TriStar Technology Ventures, a healthcare innovation venture firm, as well as the appointment of John Doulis, CIO of TriStar’s partner fund, MedCare Investment Funds, to the company’s Board Of Directors.

As Chief Information Officer of MedCare, Dr. Doulis brings 20 years of experience as a physician, executive, scientist, and architect and manager of healthcare information systems.

Prior to MedCare, Dr. Doulis was Assistant Vice Chancellor and Chief Operations Officer of the Informatics Center at Vanderbilt University, leading the Informatics Center’s efforts to provide the most effective information technology infrastructure possible to the diverse operating units within VUMC.

John Doulis joins current GenomOncology Board members Manuel J. Glynias, President and CEO of GenomOncology, Bradley Wertz, former President and COO of Rosetta, and Lee Zapis, principal of Zapis Capital Group.

“We are very pleased to welcome Dr. Doulis to our Board of Directors,” said Manuel Glynias, President and CEO of GenomOncology. “His strong healthcare and informatics experience will compliment the expertise of our other Board members, ensuring that GenomOncology will be prepared to fully leverage the opportunities presented by this very dynamic market.”

“As the use of NGS data transitions from the research lab to the bedside, GenomOncology’s innovative technology and business model position the company to accelerate this transformation,” said Dr. Doulis. “I look forward to helping GenomOncology achieve its full potential.”
Brian Laden, Partner and Vice President at TriStar Technology Ventures, will join Dr. Doulis in working closely with the company. “GenomOncology has created a best-in-class product offering that allows pathologists to leverage the power of NGS without having to outsource the work to a third party or build an internal bioinformatics team. With their outstanding management team, they have positioned the company to capitalize on the rapidly expanding market for DNA-based molecular diagnostics.”

In collaboration with researchers and physicians, GenomOncology has developed two proprietary software platforms that streamline the use of NGS in medicine and research: GO Clinical Workbench™ for the clinical laboratory and GenomAnalytics™ for research applications. Software implementation occurs inside the client’s firewall, alleviating HIPAA concerns.

For the clinical laboratory, the platform is configured to each client’s specific needs with clinical systems (LIMS, EMR, etc.) integration, setting of quality control and annotation parameters, and design of the resultant clinical report. For researchers, the platform is updated on a monthly basis, adding new features and functions based on individualized research interests and use. In both environments, GenomOncology provides onsite experts in bioinformatics and genomics to leverage the platform to support each client’s current and future needs.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenomOncology to Present at Cleveland Clinic Medical Innovation Summit
Manuel Glynias will present at the Summit on Wednesday October 29 at the Cleveland Convention Center in Room 26.
Saturday, October 25, 2014
GenomOncology Collaborates with Roswell Park Cancer Institute
Collaboration on informatics solution for next-generation sequencing.
Wednesday, February 12, 2014
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
New NIH-EPA Research Centers to Study Environmental Health Disparities
Scientists will partner with community organizations to study these concerns and develop culturally appropriate ways to reduce exposure to harmful environmental conditions.
Structure of Essential Digestive Enzyme Uncovered
Using a powerful combination of techniques from biophysics to mathematics, researchers have revealed new insights into the mechanism of a liver enzyme that is critical for human health.
Air Pollution Linked to Heart Disease
10-year project revealed air pollutants accelerate plaque build-up in arteries to the heart.
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Following Tricky Triclosan
Antibacterial product flows through streams, crops.
Vitamin A May Help Improve Pancreatic Cancer Chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London (QMUL).
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!